Physician profile
Michael A Kavanagh
NPI 1588655740
$956.16
in general payments reported to CMS, 2019-2025
9 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $34.95 · 2021: $28.04 · 2022: $71.84 · 2023: $75.70 · 2024: $182 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $211.28 | 2019-2025 | Orthovisc, Monovisc, Peak |
| Stryker Corporation | $178.76 | 2019 | |
| Bioventus LLC | $175.26 | 2022-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Medacta USA, INC. | $147.49 | 2024 | |
| Supreme Orthopedic Systems, LLC | $64.97 | 2025 | |
| Pacira Therapeutics, INC. | $62.99 | 2020-2021 | |
| Heron Therapeutics, INC. | $50.98 | 2022-2023 | Zynrelef |
| Becton, Dickinson and Company | $34.42 | 2024 | |
| Smith+Nephew, INC. | $30.01 | 2022-2023 | Bone Anchors With Arthroscopic Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kavanagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.